Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients

M. M. Kincaid, P. D. Harvey, M. Parrella, L. White, K. M. Putnam, P. Powchik, M. Davidson, R. C. Mohs

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

This study examined the usefulness of the Alzheimer's Disease Assessment Scale-Late Version (ADAS-L) for assessing cognitive and behavioral impairment in geriatric schizophrenic patients. Subjects were 339 geriatric schizophrenic inpatients. Discriminant function analyses compared the Mini-Mental State Examination (MMSE) with the ADAS-L as independent variables predicting the level of impairment on the criterion measure, the Clinical Dementia Rating. The ADAS-L surpassed the MMSE at correctly distinguishing severe to profound impairment; the MMSE was superior for identifying absent or questionable impairment. Findings provide evidence for the concurrent validity of the ADAS-L as an instrument for measuring impairment in geriatric schizophrenic inpatients.

Original languageEnglish (US)
Pages (from-to)76-81
Number of pages6
JournalJournal of Neuropsychiatry and Clinical Neurosciences
Volume7
Issue number1
StatePublished - Jan 1 1995
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Validity and utility of the ADAS-L for measurement of cognitive and functional impairment in geriatric schizophrenic inpatients'. Together they form a unique fingerprint.

  • Cite this